Exercise

YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting

Retrieved on: 
Saturday, February 17, 2024

The following persons be elected as Directors with immediate effect: (i) Ms Nan Zhang; (ii) Ms Yun (Monica) Zhang; (iii) Mr Lui Chi Keung (Peter); (iv) Mr Jing Xian Li.

Key Points: 
  • The following persons be elected as Directors with immediate effect: (i) Ms Nan Zhang; (ii) Ms Yun (Monica) Zhang; (iii) Mr Lui Chi Keung (Peter); (iv) Mr Jing Xian Li.
  • As of the close of business on the EGM's record date of February 8, 2024, the Company had 188,327,959 ordinary shares issued and outstanding.
  • The results of the vote on each of the resolutions submitted for shareholder approval at the EGM were zero vote in favor and 97,272,542 votes against.
  • Further, Article 88 of the Articles permits a director to attend and be heard on any motion for his removal.

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Friday, February 16, 2024

The aggregate gross proceeds to Larimar from this offering, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $172.5 million.

Key Points: 
  • The aggregate gross proceeds to Larimar from this offering, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $172.5 million.
  • Leerink Partners, Citigroup and Guggenheim Securities acted as joint bookrunning managers for the offering.
  • LifeSci Capital acted as lead manager for the offering.
  • The shares were offered pursuant to a shelf registration statement on Form S-3 (File No.

Immunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Friday, February 16, 2024

Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced the closing of its underwritten public offering of 10,000,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,500,000 shares, at a price to the public of $20.00 per share.

Key Points: 
  • Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced the closing of its underwritten public offering of 10,000,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,500,000 shares, at a price to the public of $20.00 per share.
  • The gross proceeds to Immunome from the offering, before deducting underwriting discounts and commissions and offering expenses, are $230.0 million.
  • All of the shares in the offering were sold by Immunome.
  • J.P. Morgan, TD Cowen, Leerink Partners and Guggenheim Securities acted as joint book-running managers for the offering.

ToughBuilt Industries Announces Closing of $3.5 Million Public Offering

Retrieved on: 
Friday, February 16, 2024

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Key Points: 
  • H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
  • The gross proceeds to the Company from the offering were approximately $3.5 million, before deducting the placement agent’s fees and other offering expenses payable by ToughBuilt.
  • The Company intends to use the net proceeds from this offering for general corporate purposes, including working capital.
  • The offering was made only by means of a prospectus, which is part of the effective registration statement.

Martians Wanted: NASA Opens Call for Simulated Yearlong Mars Mission

Retrieved on: 
Friday, February 16, 2024

WASHINGTON, Feb. 16, 2024 /PRNewswire/ -- NASA is seeking applicants to participate in its next simulated one-year Mars surface mission to help inform the agency's plans for human exploration of the Red Planet.

Key Points: 
  • WASHINGTON, Feb. 16, 2024 /PRNewswire/ -- NASA is seeking applicants to participate in its next simulated one-year Mars surface mission to help inform the agency's plans for human exploration of the Red Planet.
  • Each CHAPEA mission involves a four-person volunteer crew living and working inside a 1,700-square-foot, 3D-printed habitat based at NASA's Johnson Space Center in Houston.
  • The habitat, called the Mars Dune Alpha, simulates the challenges of a mission on Mars, including resource limitations, equipment failures, communication delays, and other environmental stressors.
  • With the first CHAPEA crew more than halfway through their yearlong mission, NASA is using research gained through the simulated missions to help inform crew health and performance support during Mars expeditions.

HUGOTON ROYALTY TRUST DECLARES NO FEBRUARY CASH DISTRIBUTION

Retrieved on: 
Friday, February 16, 2024

However, after the partial recovery, there were no remaining proceeds from the properties underlying the Oklahoma net profits interests to be included in the current month's distribution.

Key Points: 
  • However, after the partial recovery, there were no remaining proceeds from the properties underlying the Oklahoma net profits interests to be included in the current month's distribution.
  • XTO Energy has estimated the amount to be approximately $14.6 million (net to the Trust).
  • As of the date hereof, $9.1 million underlying ($7.3 million net to the Trust) in development costs have been charged to the Trust for the three non-operated wells.
  • For more information on the Trust, including the annual tax information, distribution amounts, and historical press releases, please visit our website at www.hgt-hugoton.com .

Candidates’ aging brains are factors in the presidential race − 4 essential reads

Retrieved on: 
Friday, February 16, 2024

The leading contenders in the 2024 presidential election are two of the three oldest people ever to serve as president.

Key Points: 
  • The leading contenders in the 2024 presidential election are two of the three oldest people ever to serve as president.
  • Both Biden and Trump have faced criticism about what can appear to be obvious signs of aging, including questions about their memory and cognitive abilities.
  • Scholars writing for The Conversation U.S. have discussed various aspects of how aging affects people’s brains.
  • Key factors include the strength of a person’s social connections, as well as their sleeping habits, water consumption, exercise and diet.

"Children Are Crashing Out," ARCA Organizer Says

Retrieved on: 
Friday, February 16, 2024

LOS ANGELES, Feb. 16, 2024 /PRNewswire/ -- "Children are not only taking the lives of each other, but also the lives of adults, and for the traumatized children who do make it into adulthood, it's only a matter of time before they self-destruct and it's not always because of a mental illness, but for their lack of not being able to control their emotions due to the nonexistence of emotional intelligence never intentionally taught in the home or public school." These are the words of Antonio Ricardo Cannady, the organizer behind the Antonio Ricardo Cannady Act (ARCA) initiative, who says that it's not only necessary that Congress and the United States Board of Education intervene and vote ARCA into federal law and that it's their duty to do so.

Key Points: 
  • The Antonio Ricardo Cannady Act (ARCA) initiative will pressure Congress and the United States Board of Education to mandate emotional intelligence courses.
  • These are the words of Antonio Ricardo Cannady, the organizer behind the Antonio Ricardo Cannady Act (ARCA) initiative, who says that it's not only necessary that Congress and the United States Board of Education intervene and vote ARCA into federal law and that it's their duty to do so.
  • After all, single parents are too busy earning a living to raise their children, and the educational system isn't required to do so.
  • Here is an example of ARCA at work in the classroom.

Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds

Retrieved on: 
Friday, February 16, 2024

The resale of the shares of common stock issuable upon exercise of the warrant were registered pursuant to an effective registration statement on Form S-1 (No.

Key Points: 
  • The resale of the shares of common stock issuable upon exercise of the warrant were registered pursuant to an effective registration statement on Form S-1 (No.
  • In consideration for the immediate exercise of the existing warrant for cash, Hepion has agreed to issue to the investor two new unregistered warrants, each to purchase 735,295 shares of common stock (or an aggregate of 1,470,590 shares) at an exercise price of $1.91 per share.
  • Such warrants are identical, except that one warrant has a term of five years and the second warrant has a term of eighteen months.
  • Hepion intends to use the net proceeds from the exercise for general corporate purposes.